There are numerous formulations of aspirin available over-the-counter often advertised to decrease gastric issues. Join host, Geoff Wall, as he evaluates a new study to see if enteric aspirin is worth the extra money and effort.
 
The GameChanger
Buffered and coated aspirin are purported to cause fewer gastric adverse events. However, no efficacy or safety differences exist in the various formulations of aspirin.

Host
Geoff Wall, PharmD, BCPS, FCCP, BCGP
Professor of Pharmacy Practice, Drake University
Internal Medicine/Critical Care, UnityPoint Health
 
Reference
Sleem A, Effron MB, Stebbins A, et al. Effectiveness and Safety of Enteric-Coated vs Uncoated Aspirin in Patients With Cardiovascular Disease: A Secondary Analysis of the ADAPTABLE Randomized Clinical Trial. JAMA Cardiol. Published online October 04, 2023. doi:10.1001/jamacardio.2023.3364

https://jamanetwork.com/journals/jamacardiology/fullarticle/2809795?resultClick=1
 
Pharmacist Members, REDEEM YOUR CPE HERE!
 
Not a member? Get a Pharmacist Membership & earn CE for GameChangers Podcast episodes! (30 mins/episode)


CPE Information
 
Learning Objectives
Upon successful completion of this knowledge-based activity, participants should be able to:
1. Discuss the history of various formulations of aspirin on the US market
2. Discuss the results and limitations of the ADAPTABLE study

0.05 CEU/0.5 Hr
UAN: 0107-0000-23-331-H01-P
Initial release date: 10/30/2023
Expiration date: 10/30/2024
Additional CPE details can be found here.

Follow CEimpact on Social Media:
LinkedIn
Instagram